Richard Malamut - Net Worth and Insider Trading
Richard Malamut Net Worth
The estimated net worth of Richard Malamut is at least $104,384 dollars as of 2025-05-01. Richard Malamut is the Director of Channel Therapeutics Corp and owns about 91,565 shares of Channel Therapeutics Corp (CHRO) stock worth over $104,384. Details can be seen in Richard Malamut's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Richard Malamut has not made any transactions after 2024-09-12 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Richard Malamut
Richard Malamut Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Richard Malamut owns 1 companies in total, including Collegium Pharmaceutical Inc (COLL) .
Click here to see the complete history of Richard Malamut’s form 4 insider trades.
Insider Ownership Summary of Richard Malamut
| Ticker | Company | Transaction Date | Type of Owner |
|---|---|---|---|
| COLL | Collegium Pharmaceutical Inc | 2022-02-10 | EVP and Chief Medical Officer |
Richard Malamut Latest Holdings Summary
Richard Malamut currently owns a total of 1 stock. Richard Malamut owns 91,565 shares of Channel Therapeutics Corp (CHRO) as of September 12, 2024, with a value of $104,384.
Latest Holdings of Richard Malamut
| Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CHRO | Channel Therapeutics Corp | 2024-09-12 | 91,565 | 1.14 | 104,384 |
Holding Weightings of Richard Malamut
Richard Malamut Form 4 Trading Tracker
According to the SEC Form 4 filings, Richard Malamut has made a total of 1 transactions in Channel Therapeutics Corp (CHRO) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Channel Therapeutics Corp is the acquisition of 10,400 shares on September 12, 2024, which cost Richard Malamut around $9,776.
Insider Trading History of Richard Malamut
- 1
Richard Malamut Trading Performance
GuruFocus tracks the stock performance after each of Richard Malamut's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Richard Malamut is -29.67%. GuruFocus also compares Richard Malamut's trading performance to market benchmark return within the same time period. The performance of stocks bought by Richard Malamut within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Richard Malamut's insider trading performs compared to the benchmark.
Performance of Richard Malamut
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -42.22 |  | | | | |
| Relative Return to S&P 500(%) | -46.14 | | | | | |
Richard Malamut Ownership Network
Ownership Network List of Richard Malamut
Ownership Network Relation of Richard Malamut
Richard Malamut Owned Company Details
What does Collegium Pharmaceutical Inc do?
Who are the key executives at Collegium Pharmaceutical Inc?
Richard Malamut is the EVP and Chief Medical Officer of Collegium Pharmaceutical Inc. Other key executives at Collegium Pharmaceutical Inc include EVP & Chief Financial Officer Tupper Colleen , EVP & Chief Commercial Officer Scott Dreyer , and EVP and General Counsel Shirley R. Kuhlmann .
Collegium Pharmaceutical Inc (COLL) Insider Trades Summary
Over the past 18 months, Richard Malamut made no insider transaction in Collegium Pharmaceutical Inc (COLL). Other recent insider transactions involving Collegium Pharmaceutical Inc (COLL) include a net sale of 201,056 shares made by Scott Dreyer , a net sale of 184,392 shares made by Shirley R. Kuhlmann , and a net sale of 42,187 shares made by Tupper Colleen .
In summary, during the past 3 months, insiders sold 168,024 shares of Collegium Pharmaceutical Inc (COLL) in total and bought 0 shares, with a net sale of 168,024 shares. During the past 18 months, 539,338 shares of Collegium Pharmaceutical Inc (COLL) were sold and 0 shares were bought by its insiders, resulting in a net sale of 539,338 shares.
Collegium Pharmaceutical Inc (COLL)'s detailed insider trading history can be found in Insider Trading Tracker table.
Collegium Pharmaceutical Inc Insider Transactions
Richard Malamut Mailing Address
Above is the net worth, insider trading, and ownership report for Richard Malamut. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Richard Malamut's mailing address is: Stoughton Ma 02072.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
